Updated Apr. 24, 2013 at 6:15 a.m.

Premium Lock Troubled Tranzyme to merge with California firm in all-stock deal

Published: 2013-04-24 00:13:00
Updated: 2013-04-24 06:15:35

Tranzyme Pharma Tranzyme logo

Tranzyme Pharma is merging with privately held San Diego company Ocera Therapeutics in an all stock deal that gives Ocera a public listing and Tranzyme a path forward after seeing its two lead compounds fail in clinical trials last year....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Dr. Mike Walden
Tech economy
Vivek Wadhwa
Commentary
Frank Vinluan
Life science
Scroll